Provided by Tiger Trade Technology Pte. Ltd.

Century Therapeutics, Inc.

2.07
+0.05002.48%
Post-market: 2.130.0600+2.90%19:30 EDT
Volume:330.59K
Turnover:680.42K
Market Cap:374.67M
PE:-2.23
High:2.09
Open:2.05
Low:2.02
Close:2.02
52wk High:3.04
52wk Low:0.4350
Shares:181.00M
Float Shares:101.00M
Volume Ratio:0.80
T/O Rate:0.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9300
EPS(LYR):-0.1107
ROE:-49.65%
ROA:-23.51%
PB:1.61
PE(LYR):-18.70

Loading ...

Piper Sandler Reaffirms Their Buy Rating on Century Therapeutics (IPSC)

TIPRANKS
·
Jun 09

Century Therapeutics Advances CNTY-813 Diabetes Cell Therapy

TIPRANKS
·
Jun 09

Century Therapeutics targets CNTY-813 type 1 diabetes IND filing in Q4 2026

Reuters
·
Jun 09

New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026

GlobeNewswire
·
Jun 09

Mizuho Initiates Century Therapeutics at Outperform

MT Newswires Live
·
Jun 04

Century Therapeutics Inc : Mizuho Initiates Coverage With Outperform Rating; Target Price $8

THOMSON REUTERS
·
Jun 04

Mizuho Initiates Century Therapeutics at Outperform

MT Newswires Live
·
May 27

Century Therapeutics Inc : Mizuho Initiates Coverage With Outperform Rating; Target Price $8

THOMSON REUTERS
·
May 27

Century Therapeutics initiated with an Outperform at Mizuho

TIPRANKS
·
May 27

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 27

U.S. RESEARCH ROUNDUP- Agilent Technologies, Fedex, Synopsys

Reuters
·
May 27

Analysts Are Bullish on Top Healthcare Stocks: Invivyd (IVVD), Century Therapeutics (IPSC)

TIPRANKS
·
May 19

Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors

THOMSON REUTERS
·
May 14

Century Therapeutics reports Q1 EPS (11c), consensus (17c)

TIPRANKS
·
May 14

Analysts Are Bullish on Top Healthcare Stocks: Aura Biosciences Inc (AURA), Century Therapeutics (IPSC)

TIPRANKS
·
May 13

Century Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Century Therapeutics Q1 EPS $(0.11) Beats $(0.17) Estimate

Benzinga Earnings
·
May 13

Century Therapeutics posts smaller-than-expected Q1 net loss on lower R&D spend

Reuters
·
May 13

BRIEF-Century Therapeutics Q1 Net Income USD -21.645 Million

Reuters
·
May 13

Century Therapeutics Q1 Basic EPS USD -0.11

THOMSON REUTERS
·
May 13